✦ LIBER ✦

Induction of specific CTL by MAGE-3/CEA peptide-pulsed dendritic cells from HLA-A2/A24+gastrointestinal cancer patients

✍ Scribed by Xishan Hao; Ying Shao; Xiubao Ren; Hong Liu; Qi Xu; Hui Li; Peng Zhang; Xiumei An; Baozhu Ren

Publisher: Springer-Verlag
Year: 2002
Tongue: English
Weight: 181 KB
Volume: 128
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-002-0358-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction of human leukocyte antigen (HL

Induction of human leukocyte antigen (HLA)-A2-restricted and MAGE-3-gene-derived peptide-specific cytolytic T lymphocytes using cultured dendritic cells from an HLA-A2 esophageal cancer patient

✍ Kanaoka, Shunji; Yamasaki, Seiji; Okino, Takashi; Inoue, Naoya; Shimada, Yutaka; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Background and objectives: Using peripheral blood mononuclear cells (pbmcs) from a 10-year survivor with established human leukocyte antigen (hla)-a2(+) and mage-3(+) esophageal cancer cell line (kyse-170), we examined the induction of hla-a2-restricted and mage-3-gene-derived peptide (flwgpralv

Enhanced induction of dendritic cell mat

Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8+CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells

✍ Shengming Dai; Xiangyang Zhou; Baomei Wang; Qingqing Wang; Yangxin Fu; Taoyong C 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 475 KB

Report of immune monitoring of prostate

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

✍ Salgaller, Michael L.; Lodge, Patricia A.; McLean, Joanne G.; Tjoa, Ben A.; Loft 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

## BACKGROUND. In this paper we describe our program for the immune monitoring of phase II participants given dendritic cell (DC)/prostate-specific membrane antigen (PSMA)-based immunotherapy, and we also present some initial findings. METHODS. Phase II subjects received six administrations of aut

Infusion of dendritic cells pulsed with

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

✍ Murphy, G.P.; Tjoa, B.A.; Simmons, S.J.; Jarisch, J.; Bowes, V.A.; Ragde, H.; Ro 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 2 views

## Background: A phase ii trial was conducted to assess the efficacy of infusions of dendritic cells (dc) and two hla-a2-specific psma peptides (psm-p1 and -p2). this report describes thirty three subjects with hormone-refractory metastatic prostate cancer without prior vaccine therapy history who